368 related articles for article (PubMed ID: 10661335)
1. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?
Nieder C; Nestle U; Motaref B; Walter K; Niewald M; Schnabel K
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):297-302. PubMed ID: 10661335
[TBL] [Abstract][Full Text] [Related]
2. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
3. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
Gaspar L; Scott C; Rotman M; Asbell S; Phillips T; Wasserman T; McKenna WG; Byhardt R
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):745-51. PubMed ID: 9128946
[TBL] [Abstract][Full Text] [Related]
4. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.
Videtic GM; Adelstein DJ; Mekhail TM; Rice TW; Stevens GH; Lee SY; Suh JH
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):240-3. PubMed ID: 17056192
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases.
Agboola O; Benoit B; Cross P; Da Silva V; Esche B; Lesiuk H; Gonsalves C
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):155-9. PubMed ID: 9747833
[TBL] [Abstract][Full Text] [Related]
6. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.
Gaspar LE; Scott C; Murray K; Curran W
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1001-6. PubMed ID: 10863071
[TBL] [Abstract][Full Text] [Related]
7. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
[TBL] [Abstract][Full Text] [Related]
8. Patients with brain metastases: hope for recursive partitioning analysis (RPA) class 3.
Lutterbach J; Bartelt S; Stancu E; Guttenberger R
Radiother Oncol; 2002 Jun; 63(3):339-45. PubMed ID: 12142098
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
10. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.
Kepka L; Cieslak E; Bujko K; Fijuth J; Wierzchowski M
Acta Oncol; 2005; 44(4):389-98. PubMed ID: 16120548
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.
Paravati AJ; Heron DE; Landsittel D; Flickinger JC; Mintz A; Chen YF; Huq MS
J Neurooncol; 2011 Aug; 104(1):339-49. PubMed ID: 21181233
[TBL] [Abstract][Full Text] [Related]
12. Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis.
Videtic GM; Gaspar LE; Zamorano L; Stitt LW; Fontanesi J; Levin KJ
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):963-8. PubMed ID: 11704318
[TBL] [Abstract][Full Text] [Related]
13. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
16. Radiosurgery for brain metastases: a score index for predicting prognosis.
Weltman E; Salvajoli JV; Brandt RA; de Morais Hanriot R; Prisco FE; Cruz JC; de Oliveira Borges SR; Wajsbrot DB
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1155-61. PubMed ID: 10725626
[TBL] [Abstract][Full Text] [Related]
17. Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.
Hendriks LE; Troost EG; Steward A; Bootsma GP; De Jaeger K; van den Borne BE; Dingemans AM
Acta Oncol; 2014 Jul; 53(7):945-51. PubMed ID: 24754845
[TBL] [Abstract][Full Text] [Related]
18. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.
Sanghavi SN; Miranpuri SS; Chappell R; Buatti JM; Sneed PK; Suh JH; Regine WF; Weltman E; King VJ; Goetsch SJ; Breneman JC; Sperduto PW; Scott C; Mabanta S; Mehta MP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):426-34. PubMed ID: 11567817
[TBL] [Abstract][Full Text] [Related]
19. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
Murray KJ; Scott C; Greenberg HM; Emami B; Seider M; Vora NL; Olson C; Whitton A; Movsas B; Curran W
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):571-4. PubMed ID: 9336134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]